Healthy world is a clear vision and all our research is focused towards achieving it. The products that are currently in Phase III are purely skincare products. However, the pipeline is very well balanced in terms of therapy areas as well as launch timelines to suit the most desired healthcare needs.
The healthcare management has been very dynamic and so is our Research & Development methodology. We believe in portfolio and not a product so as to be able to address a disease completely. Our R&D team, hence, is smartly selected by us, with an experience of serving research in more than one therapy area and more than one aspect of the process.

Our pipeline

R&D Partnership
Clinical Trials